NRx Pharmaceuticals Closes $11 Million Unsecured Debt Financing
- Monday, November 7, 2022, 7:00
- Finance
- Add a comment
RADNOR, Pa., Nov. 7, 2022 /PRNewswire/ — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals” or the “Company”), a clinical-stage CNS biopharmaceutical company, today announced that it has obtained approximately $11 million in unsecured debt financing (the “Note”) from…
About the Author
adminasapcorp has written 41785 stories on this site.